Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Fusion Biopsy Market
5.1. COVID-19 Landscape: Fusion Biopsy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Fusion Biopsy Market, By Biopsy Route
8.1. Fusion Biopsy Market, by Biopsy Route, 2025-2033
8.1.1. Transrectal
8.1.1.1. Market Revenue and Forecast (2024-2033)
8.1.2. Transperineal
8.1.2.1. Market Revenue and Forecast (2024-2033)
Chapter 9. Global Fusion Biopsy Market, By End Use
9.1. Fusion Biopsy Market, by End Use, 2025-2033
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2024-2033)
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast (2024-2033)
9.1.3. Ambulatory Care Centers
9.1.3.1. Market Revenue and Forecast (2024-2033)
Chapter 10. Global Fusion Biopsy Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.1.2. Market Revenue and Forecast, by End Use (2024-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.1.3.2. Market Revenue and Forecast, by End Use (2024-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.1.4.2. Market Revenue and Forecast, by End Use (2024-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.2.2. Market Revenue and Forecast, by End Use (2024-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.2.3.2. Market Revenue and Forecast, by End Use (2024-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.2.4.2. Market Revenue and Forecast, by End Use (2024-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.2.5.2. Market Revenue and Forecast, by End Use (2024-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.2.6.2. Market Revenue and Forecast, by End Use (2024-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.3.2. Market Revenue and Forecast, by End Use (2024-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.3.3.2. Market Revenue and Forecast, by End Use (2024-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.3.4.2. Market Revenue and Forecast, by End Use (2024-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.3.5.2. Market Revenue and Forecast, by End Use (2024-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.3.6.2. Market Revenue and Forecast, by End Use (2024-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.4.2. Market Revenue and Forecast, by End Use (2024-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.4.3.2. Market Revenue and Forecast, by End Use (2024-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.4.4.2. Market Revenue and Forecast, by End Use (2024-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.4.5.2. Market Revenue and Forecast, by End Use (2024-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.4.6.2. Market Revenue and Forecast, by End Use (2024-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.5.2. Market Revenue and Forecast, by End Use (2024-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.5.3.2. Market Revenue and Forecast, by End Use (2024-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Biopsy Route (2024-2033)
10.5.4.2. Market Revenue and Forecast, by End Use (2024-2033)
Chapter 11. Company Profiles
11.1. Eigen
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Koninklijke Philips N.V.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hitachi Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. MedCom
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. ESAOTE SPA
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. KOELIS
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Focal Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. BK Medical Holding Company, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Exact Imaging
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biobot Surgical Pte Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. UC-Care Medical Systems Ltd
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
著作権 ©2022 無断複写・転載を禁じます
